iA Global Asset Management Inc. raised its holdings in shares of Zoetis Inc. (NYSE:ZTS - Free Report) by 600.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 25,504 shares of the company's stock after buying an additional 21,862 shares during the period. iA Global Asset Management Inc.'s holdings in Zoetis were worth $4,983,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Darwin Wealth Management LLC acquired a new position in shares of Zoetis during the third quarter worth $31,000. First Personal Financial Services acquired a new position in shares of Zoetis during the third quarter worth $33,000. Capital Performance Advisors LLP acquired a new position in shares of Zoetis during the third quarter worth $33,000. Quarry LP lifted its position in shares of Zoetis by 273.2% during the second quarter. Quarry LP now owns 209 shares of the company's stock worth $36,000 after purchasing an additional 153 shares in the last quarter. Finally, Fortitude Family Office LLC lifted its position in shares of Zoetis by 1,387.5% during the third quarter. Fortitude Family Office LLC now owns 238 shares of the company's stock worth $46,000 after purchasing an additional 222 shares in the last quarter. 92.80% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
ZTS has been the topic of a number of recent research reports. Leerink Partners initiated coverage on shares of Zoetis in a research report on Monday, December 2nd. They set an "outperform" rating and a $215.00 target price on the stock. Piper Sandler upped their price target on shares of Zoetis from $195.00 to $210.00 and gave the company an "overweight" rating in a report on Wednesday, August 14th. Leerink Partnrs raised shares of Zoetis to a "strong-buy" rating in a report on Monday, December 2nd. BTIG Research upped their price target on shares of Zoetis from $220.00 to $225.00 and gave the company a "buy" rating in a report on Monday, August 12th. Finally, Stifel Nicolaus upped their price target on shares of Zoetis from $200.00 to $210.00 and gave the company a "buy" rating in a report on Wednesday, September 18th. Ten equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus target price of $219.00.
Read Our Latest Stock Report on Zoetis
Zoetis Stock Performance
ZTS stock traded up $1.69 during trading on Friday, hitting $176.46. 2,551,210 shares of the company's stock traded hands, compared to its average volume of 2,537,907. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26. Zoetis Inc. has a 52 week low of $144.80 and a 52 week high of $201.92. The stock has a fifty day moving average price of $182.07 and a two-hundred day moving average price of $181.07. The stock has a market capitalization of $79.61 billion, a price-to-earnings ratio of 33.17, a price-to-earnings-growth ratio of 2.88 and a beta of 0.89.
Zoetis (NYSE:ZTS - Get Free Report) last released its earnings results on Monday, November 4th. The company reported $1.58 earnings per share for the quarter, beating the consensus estimate of $1.46 by $0.12. The firm had revenue of $2.40 billion during the quarter, compared to analyst estimates of $2.29 billion. Zoetis had a net margin of 26.55% and a return on equity of 51.98%. The firm's revenue for the quarter was up 11.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.36 earnings per share. As a group, equities analysts anticipate that Zoetis Inc. will post 5.9 EPS for the current fiscal year.
Zoetis Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Tuesday, December 3rd. Stockholders of record on Thursday, October 31st were given a dividend of $0.432 per share. The ex-dividend date of this dividend was Thursday, October 31st. This represents a $1.73 annualized dividend and a dividend yield of 0.98%. Zoetis's dividend payout ratio is currently 32.52%.
About Zoetis
(
Free Report)
Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.
Featured Articles
Before you consider Zoetis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zoetis wasn't on the list.
While Zoetis currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.